Skip to main content

Connor, Clark & Lunn Investment Management Ltd.

Position in AUPH — Aurinia Pharmaceuticals Inc.

CIK 1596800 VANCOUVER, A1

Position in AUPH

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$6,931,447
+$1,071,545 QoQ
Shares Held
408,453
+3.3% QoQ
Ownership
0.307%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#32
of 279 holders
Holding Since
Mar 2020
14 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in AUPH Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Connor, Clark & Lunn Investment Management Ltd. holds $650,455,383 across 105 Biotechnology names. AUPH ranks #24 (1.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in AUPH

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $6,931,447 408,453
2026-03-31 $5,859,902 395,405
2025-12-31 $6,118,786 383,623
2025-09-30 $5,980,127 541,188
2025-06-30 $5,507,117 650,191
2025-03-31 $5,999,681 746,229
2024-12-31 $4,996,956 556,454
2024-09-30 $3,329,718 454,259
2021-06-30 $4,756,320 367,000
2021-03-31 $5,660,317 435,912
2020-12-31 $27,659,612 1,999,972
2020-09-30 $23,872,793 1,620,692
2020-06-30 $23,625,875 1,453,900
2020-03-31 $15,635,540 1,077,570